Literature DB >> 18797151

PPAR alpha and PPAR delta transactivity and p300 binding activity induced by arachidonic acid in colorectal cancer cell line Caco-2.

Kazuki Mochizuki1, Takuji Suzuki, Toshinao Goda.   

Abstract

It is reported that arachidonic acid strongly induces the conformational change in vitro and transactivity of PPAR alpha in colorectal cancer cell line Caco-2. In this study, we demonstrated that the induction of conformational change and transactivity of PPAR delta by arachidonic acid, as well as other polyunsaturated fatty acids, was considerably lower than that of PPAR alpha. Mammalian two-hybrid assay showed that arachidonic acid enhanced binding of one of the coactivators, p300, to PPAR alpha but not to PPAR delta. Additionally, arachidonic acid induced in vitro binding of both PPAR alpha-RXR alpha and PPAR delta-RXR alpha heterodimers to several PPREs on CRBPII, L-FABP and ACO genes. Our results suggest that the lower transactivity of PPAR delta for arachidonic acid in Caco-2 cells, compared with PPAR alpha, is associated with the binding activity of p300 to the receptor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18797151     DOI: 10.3177/jnsv.54.298

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  3 in total

Review 1.  PPAR Alpha as a Metabolic Modulator of the Liver: Role in the Pathogenesis of Nonalcoholic Steatohepatitis (NASH).

Authors:  Simona Todisco; Anna Santarsiero; Paolo Convertini; Giulio De Stefano; Michele Gilio; Vito Iacobazzi; Vittoria Infantino
Journal:  Biology (Basel)       Date:  2022-05-23

2.  Coactivators in PPAR-Regulated Gene Expression.

Authors:  Navin Viswakarma; Yuzhi Jia; Liang Bai; Aurore Vluggens; Jayme Borensztajn; Jianming Xu; Janardan K Reddy
Journal:  PPAR Res       Date:  2010-08-05       Impact factor: 4.964

Review 3.  Retinol-binding protein 2 (RBP2): biology and pathobiology.

Authors:  William S Blaner; Pierre-Jacques Brun; Rossana M Calderon; Marcin Golczak
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-05-28       Impact factor: 8.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.